NSE filing, NSE: NIVABUPA. Summary written from the filing by ALFA Finder's alert engine.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹78.00
- Market cap
- ₹14,435 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 40.1×Sector 19.4×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Board Meeting Outcome
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
Niva Bupa Health Insurance Company Investor Presentation: Key Takeaways
H1 FY27 GWP ₹4,634 Cr (+33.4% y-o-y, 1/n basis); PAT ₹273.4 Cr, more than doubled; CISR improved to 99.5% from 103.1%; retail health share 11.0%.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa Health Insurance's Board approved the amendment and consolidation of its UPSI Fair Disclosure and Leak Inquiry policies. The integrated policy streamlines operational compliance under SEBI PIT Regulations.
Niva Bupa Health Insurance Company Q2 FY27 Results: Net Profit ₹135.6 Cr, Up 124.1% YoY
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,572 Cr (+25.5% YoY) and net profit of ₹135.6 Cr (+124.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹135.6 Cr · +124.1% YoY
Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Other results update announcements
All →Redtape Results Update
RedTape's Q2 FY27 standalone revenue fell 3.5% YoY to ₹474 Cr, while EBITDA rose 8.2% and PAT 27.3%. Big Billion Days sales shifted into Q3.
Balrampur Chini Mills Results Update
Balrampur Chini Mills reported Q2 FY27 consolidated revenue of Rs 1,876.28 crore, up 12.3%, with EBITDA up 42.4%. The company also declared an interim dividend of Rs 4.00 per share.
SMS Pharmaceuticals Results Update
SMS Pharmaceuticals released a press release on its Q2 and H1 FY27 results, showing strong growth. Management now expects FY27 revenue growth and EBITDA margins above earlier guidance.
Credo Brands Marketing Results Update
Credo Brands released H1 FY27 highlights showing revenue up 11% to Rs. 315 crore and PAT up 18%. The company remains debt-free.
SIS Results Update
SIS Limited reported record quarterly revenue of Rs 4,816 crore, up 28% YoY. Net debt to EBITDA rose to 1.24x amid negative operating cash conversion.
Chalet Hotels Results Update
Chalet Hotels reported Q2 FY27 core EBITDA up 13% to INR 2,274 Mn and consolidated PAT of INR 2,163 Mn. The press release also notes a second ATHIVA hotel opening and a tax-regime credit.